← Eichor
Study identifier: NCT07687654 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Root Coverage Performance of Restorative Materials in Class V Cavities

Condition: Gingival Recession · Non-Carious Cervical Lesions (NCCLs)  ·  Sponsor: Zeliha Başak Çakır Erdil

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This prospective randomized controlled clinical trial aims to evaluate the influence of different restorative materials placed in Class V cervical lesions on the clinical outcomes of root coverage surgery using a subepithelial connective tissue graft. Patients with Cairo RT1 (Miller Class I-II equivalent) gingival recession associated with non-carious cervical lesions or existing cervical restorations will receive one of the restorative approaches according to the study protocol. Clinical parameters, including the percentage of root coverage and soft tissue stability, will be evaluated during follow-up to determine which restorative approach provides the most favorable clinical outcome.

This description comes directly from the study's public registry record.

Talk to the study team

Zeliha B ÇAKIR ERDİL, DDS  ·  +905059444038  ·  bskcakirr@gmail.com

Metin Çalışır, Prof.DR  ·  metincalisir@adiyaman.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Faculty of Dentistry, Adıyaman UniversityAdıyaman, Merkez, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07687654